US Stock MarketDetailed Quotes
ANTX AN2 Therapeutics
- 1.570
- +0.200+14.60%
Trading Nov 29 11:37 ET
46.91MMarket Cap-788P/E (TTM)
1.580High1.470Low798.96KVolume1.480Open1.370Pre Close1.21MTurnover5.52%Turnover RatioLossP/E (Static)29.88MShares22.22052wk High0.54P/B22.72MFloat Cap0.87052wk Low--Dividend TTM14.47MShs Float23.580Historical High--Div YieldTTM8.03%Amplitude0.870Historical Low1.511Avg Price1Lot Size
AN2 Therapeutics Stock Forum
Sign in to post a comment
$AN2 Therapeutics (ANTX.US)$
I am in here for swing play. Chart looks good and insiders have been loading.
I am in here for swing play. Chart looks good and insiders have been loading.
4
1
$AN2 Therapeutics (ANTX.US)$ Reuters· 1 min ago
AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (Caused by Mycobacterium Tuberculosis) and Malaria
AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (Caused by Mycobacterium Tuberculosis) and Malaria
1
$AN2 Therapeutics (ANTX.US)$ any future for this or it will float between 1.04 and 1.07
$AN2 Therapeutics (ANTX.US)$ Bml Investment Partners, L.p. Reports 14.2% Passive Stake in AN2 Therapeutics as of August 9, 2024- SEC Filing
3
$AN2 Therapeutics (ANTX.US)$ fire sale🔥
1
$AN2 Therapeutics (ANTX.US)$ Plan to report Phase 2 topline results in August 2024 from ongoing Phase 2/3 trial (EBO-301) in treatment-refractory Mycobacterium avium Complex (TR-MAC)
Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determined after review of unblinded Phase 2 data and discussions with the FDA
Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determined after review of unblinded Phase 2 data and discussions with the FDA
1
6
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$AN2 Therapeutics (ANTX.US)$ is something brewing here
$AN2 Therapeutics (ANTX.US)$ give us $ 5
1
$AN2 Therapeutics (ANTX.US)$ So lets start here! Im basing my in on the bottom. And Y’all know i really likes me some bottoms! Hehehe! This just touched 52wk /ATL. And the daily is beyond into oversold! RSI 7= 7.91 and RSI 14=13.79! For those maybe not familiar? RSI 30 is considered OS territory. MACD has started to show signs of trying to go above giving us a golden cross. Will it? Possible. And one of my favorite indicators DPO. It also has started to ...
7
11
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
NVDAvsTSLA : Do you think they have some positive results in their pipeline tests which will be released soon?